![Huntington's disease drug: Teva Pharma settles patent dispute with Lupin, continues to litigate against Aurobindo Huntington's disease drug: Teva Pharma settles patent dispute with Lupin, continues to litigate against Aurobindo](https://medicaldialogues.in/h-upload/2020/05/07/128428-125024-patent-infringement.webp)
Huntington's disease drug: Teva Pharma settles patent dispute with Lupin, continues to litigate against Aurobindo
![Teva Branded Pharmaceutical Products R&D;, . An electronic inhaler add-on module which store and transmit information related to inhaler use (eModule) PDR0000401 FCC ID 2AJVSPDR0000401 Teva Branded Pharmaceutical Products R&D;, . An electronic inhaler add-on module which store and transmit information related to inhaler use (eModule) PDR0000401 FCC ID 2AJVSPDR0000401](https://cdn-0.fccid.io/images/device/2AJVS/PDR0000401/Internal-Photos-645EADB6.jpg)
Teva Branded Pharmaceutical Products R&D;, . An electronic inhaler add-on module which store and transmit information related to inhaler use (eModule) PDR0000401 FCC ID 2AJVSPDR0000401
![Out in Jan: 2nd Benchmark of pharma companies' actions on antibiotic resistance and access - Access to Medicine Foundation Out in Jan: 2nd Benchmark of pharma companies' actions on antibiotic resistance and access - Access to Medicine Foundation](https://accesstomedicinefoundation.org/media/uploads/files/AMRB19_webfigures_companydonut_notitle_1574168267.png)
Out in Jan: 2nd Benchmark of pharma companies' actions on antibiotic resistance and access - Access to Medicine Foundation
![Glenmark Pharma receives USFDA approval for manufacturing blood pressure tablets - Dalal Street Investment Journal Glenmark Pharma receives USFDA approval for manufacturing blood pressure tablets - Dalal Street Investment Journal](https://www.dsij.in/Portals/0/EasyDNNnews/22775/Pharma.jpg)
Glenmark Pharma receives USFDA approval for manufacturing blood pressure tablets - Dalal Street Investment Journal
![Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/510642830861510679/filePointer/510642830861510701/fodoid/510642830861510696/imageType/MEDIUM/inlineImage/true/Teva-announced-launch-of-new-daily-asthma-medicine.png)